Event Description
When life gets busy, making a real difference can feel hard. What if all it took was a few miles? Oncology Bulls and the Society of Asian Scientists and Engineers (SASE) at USF are partnering with Blood Cancer United to host the United Against Blood Cancer Virtual 5K throughout February, with a goal of raising $10,000 to support blood cancer patient care and research. Whether you run, jog, or walk, every mile helps raise funds and spread awareness for individuals and families affected by blood cancer. This flexible event allows you to participate at your own pace, on your own schedule, and from any location. Join us this February and turn your miles into meaningful impact.
Registration is now open! Secure your spot today.
To Join
- Register for the 5K Virtual (Run Anywhere).
- Complete 3.1 miles (5K) at a location of your choice during the event period.
- Save a screenshot or photo from your watch or running app as proof of completion.
- Upload your results to our website (instructions will be included in the confirmation email).
- Celebrate your accomplishment on social media! Tag @UnitedAgainstBloodCancer5k on Instagram for a chance to win a $25 Doodle Noodle Gift Card.
Registration includes:
- Blood cancer awareness ribbon pin
- Certificate of participation from Blood Cancer United
- Event lanyard
- Finisher medal
- Results posted online
Why We Run
100% of the donations and funds raised from this event are donated directly to Blood Cancer United.
Blood cancer affects lives every day. In the United States, someone is diagnosed with blood cancer every three minutes, and every nine minutes, a life is lost. Nearly 40% of childhood cancers are blood cancers, yet only 5% of cancer drugs are approved for first use in children, highlighting critical gaps in treatment and care. We are proud to support Blood Cancer United, a national non-profit organization dedicated to curing blood cancer and improving quality of life through patient care, research, and policy advocacy. Through this movement, we help support patients and families and move closer to a future where blood cancer no longer defines outcomes.
